“IQVIA is delighted to be associated for the fourth consecutive year as the main sponsor of Race for 7. While rare diseases, by virtue of their definition, affect relatively fewer number of patients, the overall number of rare disease patients is large enough to warrant more focused attention."

Winning Sales Organization

"Digital in Pharma" Special Issue. Invitation to DigiStorm2017, How to Create a Winning Sales Organization and DigiPharmaX. Avail Early Bird Discount - details inside.

How a Delhi Dementia Daycare Is Reimagining Care for India’s Forgotten Millions

By MedicinMan Editorial Desk When Memory Fades, Humanity Must Not In...

A Cardiologist Recounts his Fightback from a Near Death Covid19 Infection

In the lockdown, while I was on regular OPD and ICU rounds at a COVID hospital, I started noticing some mild symptoms of the Coronavirus infection. Being in the medical field and considering the severity of the pandemic situation then, I was very careful and cautious, and observed the symptoms closely. The symptoms persisted and I had to self-quarantine until the medical test reports came. It was important for me to isolate myself from the rest of the medical team and prevent the spread of the virus. Finally, the report came: I was COVID positive! Stunned and slightly devastated; I broke the news to my family who could not believe it either. As a doctor, I could only treat, comfort and empathize with the COVID patients undergoing treatment; completely isolated from their loved ones. But now, I could actually feel the uncertainty of the situation. I was hospitalized and continued to experience body-ache during the admission. It was a stressful situation where I felt anxious and stressed about everything. My CT scan reports showed mild lung infection on the day of admission but as the cytokines storm developed, my lungs were 76 % damaged in 3-5 days and I was short of breath and my oxygen level deteriorated to less than 80. I was shifted to an ICU with high-flow oxygen and was on a BiPap machine which I had purchased a few weeks ago for the hospital and never imagined that I would be using myself one day.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Character: The Ultimate Differentiator in Healthcare and Pharma

My friend Salil Kallianpur, in his Substack post "The...

Has the Pharmacy of the World Missed the Animal Health Bus?

In 2025, the Indian animal health market stood at...

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

Marketing

Character: The Ultimate Differentiator in Healthcare and Pharma

My friend Salil Kallianpur, in his Substack post "The...

Has the Pharmacy of the World Missed the Animal Health Bus?

In 2025, the Indian animal health market stood at...

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

Policies/Sales

Character: The Ultimate Differentiator in Healthcare and Pharma

My friend Salil Kallianpur, in his Substack post "The...

Has the Pharmacy of the World Missed the Animal Health Bus?

In 2025, the Indian animal health market stood at...

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

Strategy

Character: The Ultimate Differentiator in Healthcare and Pharma

My friend Salil Kallianpur, in his Substack post "The...

Has the Pharmacy of the World Missed the Animal Health Bus?

In 2025, the Indian animal health market stood at...

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Cipla’s Leadership Transition from Umang Vohra to Achin Gupta: Succession Planning in Action

By Anup Soans | MedicinMan Cipla Limited has announced a...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Why Private Equity is the New Kingmaker in Pharma & MedTech

The PE Playbook: Why Private Equity is the New...

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

The Pill is Now a Commodity – Can ‘Beyond the Pill’ Models Work in India?

The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered. The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model. Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison. ‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product. Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it. A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it. The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).